Kestrel Investment Management’s Cumberland Pharmaceuticals CPIX Stock Holding History

Kestrel Investment Management’s Portfolio CPIX Stock Details CPIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-137,500	Closed	-$619K	–	59
2014 Q2	$619K	Sell	137,500 -214,850	-61%	-$959K	0.08%	55
2014 Q1	$1.59M	Sell	352,350 -224,989	-39%	-$1.07M	0.2%	53
2013 Q4	$2.95M	Sell	577,339 -24,000	-4%	-$117K	0.36%	48
2013 Q3	$2.72M	Sell	601,339 -27,600	-4%	-$137K	0.28%	50
2013 Q2	$3.21M	Buy	+628,939	New	+$3.13M	0.36%	50

Other funds holding CPIX

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GHA

GW Henssler & Associates Kennesaw, Georgia $2.12B AUM 20.77% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return

Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Kestrel Investment Management's CPIX Position: Q3 2014 in Review

Kestrel Investment Management sold out of Cumberland Pharmaceuticals (CPIX) in Q3 2014, closing a stake of 137,500 shares — an estimated $619K sold.

Kestrel Investment Management first reported a position in CPIX in Q2 2013 and held it in 5 quarters. The position peaked at $3.21M in Q2 2013. 45 funds tracked by Wall St. Rank hold CPIX as of Q3 2014.

Kestrel Investment Management reported no remaining Cumberland Pharmaceuticals position as of Q3 2014 after selling out during the quarter.
Kestrel Investment Management sold 137,500 Cumberland Pharmaceuticals shares in Q3 2014, an estimated $619K.
Kestrel Investment Management first reported a position in Cumberland Pharmaceuticals in Q2 2013 and held it in 5 quarters.
Kestrel Investment Management's Cumberland Pharmaceuticals position peaked at $3.21M in Q2 2013.
45 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q3 2014.

Based on Kestrel Investment Management's 13F filing for Q3 2014, filed 12 Nov 2014.